+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study



Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study



American Journal of Psychiatry 158(11): 1843-1849



Selective serotonin reuptake inhibitors are commonly used to treat major depression; however, the percentage of serotonin (5-HT) transporter (5-HTT) sites occupied during clinical dosing is unknown. This study measured the proportion of 5-HTT sites blocked during paroxetine and citalopram treatment of depression and assessed the relationship between serum paroxetine levels and the proportion of 5-HTT sites blocked. Twelve medication-free depressed patients completed a 6-week trial of either paroxetine (N=8) or citalopram (N=4). Striatal 5-HTT binding potential was measured with [(11)C]DASB and positron emission tomography, before and after 4 weeks of treatment. The binding potential is proportional to receptor density. Striatal 5-HTT binding potential was measured twice in six healthy subjects and once in 11 healthy subjects. A significant decrease in striatal 5-HTT binding potential was found after either treatment, compared to changes found over a 4-week period in healthy subjects. For patients treated with 20 mg/day of paroxetine (N=7), the mean proportion of 5-HTT sites occupied was 83%. For patients treated with 20 mg/day of citalopram (N=4), the mean 5-HTT occupancy was 77%. 5-HTT occupancy increased in a nonlinear relationship with serum levels of paroxetine such that a plateau of occupancy around 85% occurred for serum paroxetine levels greater than 28 microg/liter. During treatment with clinical doses of paroxetine or citalopram, approximately 80% of 5-HTT receptors are occupied. This change in 5-HTT binding potential is greater than the known physiological range of changes in 5-HTT binding potential but may be necessary for some therapeutic effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046847619

Download citation: RISBibTeXText

PMID: 11691690

DOI: 10.1176/appi.ajp.158.11.1843


Related references

A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake. Bioorganic and Medicinal Chemistry 20(21): 6344-6355, 2012

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652. Psychopharmacology 164(4): 341-348, 2002

Occupancy of the serotonin reuptake sites by paroxetine during treatment of depression A 11CDASB PET study. Journal of Nuclear Medicine 42(5 Suppl.): 17P-18P, 2001

Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM. Journal of Neural Transmission 113(5): 659-670, 2006

PET [11C]DASB imaging of serotonin transporters in patients with alcoholism. Alcoholism Clinical and Experimental Research 31(1): 28-32, 2007

PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. Journal of Nuclear Medicine 47(2): 208-214, 2006

NS 4194 versus -DASB for PET imaging of serotonin transporters in living porcine brain. Synapse (New York) 49(3): 170-177, 2003

(11C)-NS 4194 versus (11C)-DASB for PET imaging of serotonin transporters in living porcine brain. Synapse (New York) 49(3): 170-177, 2003

11C]-NS 4194 versus [11C]-DASB for PET imaging of serotonin transporters in living porcine brain. Synapse 49(3): 170-177, 2003

Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment. Synapse 68(11): 548-555, 2014

Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM. Journal of Cerebral Blood Flow and Metabolism 22(11): 1377-1398, 2002

Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression. American Journal of Geriatric Psychiatry 19(12): 1016-1025, 2011

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. American Journal of Psychiatry 161(5): 826-835, 2004

Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder. Psychiatry Research 221(2): 155-161, 2014

Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. Journal of Neuroscience 26(17): 4638-4643, 2006